Sellas Life Sciences
Price & Volume
Stats
See more52W Range | $1.11-$6.14 |
Market Cap | $854.8M |
Shares Short | 53M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -82.5% |
Gross Profit (12 Mos) | $900,000 |
Diluted EPS | -$0.25 |
News
See moreYahoo Finance • 16 days ago
These 16 stocks are a short seller’s dream — likely losers no matter what the market does
Yahoo Finance • 25 days ago
SELLAS FY25 Net Loss Narrows; Approaching Final Analysis Of The Phase 3 REGAL Trial For GPS In AML
Yahoo Finance • 27 days ago
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Yahoo Finance • 4 months ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
About
CEO | Dr. Angelos M. Stergiou M.D., ScD h.c. |
CFO | Mr. John Thomas Burns CPA |
Address | 7 Times Square, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
